Ing Groep Nv Charles River Laboratories International, Inc. Transaction History

Ing Groep Nv

$14.2 Billion
Q4 2024

A detailed history of Ing Groep Nv transactions in Charles River Laboratories International, Inc. stock. As of the latest transaction made, Ing Groep Nv holds 6,531 shares of CRL stock, worth $983,046. This represents 0.01% of its overall portfolio holdings.

Number of Shares

6,531

Previous 6,905 5.42%

Holding current value

$983,046

Previous $1.36 Million 11.4%

% of portfolio

0.01%

Previous 0.01%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 03, 2025	SELL	$178.58 - $220.69 $66,788 - $82,538	-374 Reduced 5.42%	6,531 $1.21 Million
Q3 2024 Nov 06, 2024	SELL	$187.96 - $245.29 $5,074 - $6,622	-27 Reduced 0.39%	6,905 $1.36 Million
Q2 2024 Aug 13, 2024	SELL	$206.39 - $268.73 $20,019 - $26,066	-97 Reduced 1.38%	6,932 $1.43 Million
Q1 2024 May 10, 2024	BUY	$203.52 - $273.43 $1,221 - $1,640	6 Added 0.09%	7,029 $1.9 Million
Q4 2023 Feb 08, 2024	BUY	$164.52 - $238.84 $96,408 - $139,960	586 Added 9.1%	7,023 $1.66 Million
Q3 2023 Oct 27, 2023	BUY	$194.44 - $217.61 $1.25 Million - $1.4 Million	6,437 New	6,437 $1.26 Million
Q1 2023 May 09, 2023	BUY	$191.89 - $259.92 $1.66 Million - $2.25 Million	8,646 New	8,646 $1.74 Million
Q3 2022 Nov 14, 2022	SELL	$182.44 - $250.54 $289,714 - $397,857	-1,588 Reduced 16.61%	7,972 $1.57 Million
Q2 2022 Aug 08, 2022	BUY	$204.13 - $302.4 $317,218 - $469,929	1,554 Added 19.41%	9,560 $2.05 Million
Q1 2022 May 13, 2022	BUY	$255.51 - $362.11 $362,568 - $513,834	1,419 Added 21.54%	8,006 $2.27 Million
Q4 2021 Feb 11, 2022	BUY	$351.38 - $448.68 $827,851 - $1.06 Million	2,356 Added 55.68%	6,587 $2.48 Million
Q3 2021 Nov 02, 2021	BUY	$372.64 - $458.3 $38,754 - $47,663	104 Added 2.52%	4,231 $1.75 Million
Q2 2021 Aug 13, 2021	BUY	$294.17 - $371.65 $1.21 Million - $1.53 Million	4,127 New	4,127 $1.53 Million
Q3 2019 Nov 08, 2019	SELL	$125.07 - $143.67 $934,648 - $1.07 Million	-7,473 Closed	0 $0
Q2 2019 Aug 12, 2019	BUY	$123.4 - $148.55 $10,242 - $12,329	83 Added 1.12%	7,473 $1.06 Million
Q1 2019 May 13, 2019	BUY	$104.82 - $146.73 $1,886 - $2,641	18 Added 0.24%	7,390 $1.07 Million
Q4 2018 Feb 13, 2019	BUY	$105.09 - $137.23 $3,047 - $3,979	29 Added 0.39%	7,372 $834,000
Q3 2018 Nov 06, 2018	BUY	$112.11 - $134.54 $448 - $538	4 Added 0.05%	7,343 $988,000
Q2 2018 Aug 10, 2018	BUY	$102.37 - $117.25 $12,796 - $14,656	125 Added 1.73%	7,339 $824,000
Q1 2018 May 07, 2018	BUY	$98.19 - $115.2 $6,676 - $7,833	68 Added 0.95%	7,214 $770,000
Q4 2017 Feb 06, 2018	BUY	$100.43 - $118.09 $132,266 - $155,524	1,317 Added 22.59%	7,146 $782,000
Q3 2017 Nov 08, 2017	BUY	$96.72 - $109.26 $563,780 - $636,876	5,829	5,829 $630,000

Others Institutions Holding CRL

# of Institutions

710

Shares Held

49.8M

Call Options Held

122K

Put Options Held

239K

View Full List

About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.

Ticker CRL
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 50,863,300
Market Cap $7.66B
Description
Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...

More about CRL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ing Groep Nv, based on Form 13F filings with the SEC.

News

Stay updated on Ing Groep Nv with notifications on news.

Account